Advanced search
Publication Cover
Journal of Drug Assessment Volume 11, 2022 - Issue 1
Journal homepage
1,606
Views
2
CrossRef citations to date
0
Altmetric
Oncology

Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in Korea

Diego Novicka GPORWE International, Eli Lilly and Company, Windlesham, Surrey, UKCorrespondence[email protected]
,
Sae Young Leeb Medical Department, Eli Lilly and Company Korea, Seoul, Korea
,
Dong Hyun Koob Medical Department, Eli Lilly and Company Korea, Seoul, Korea
,
Agota Szendec Covance Market Access Services, Labcorp Clinical Development Limited, Leeds, UKORCID Iconhttps://orcid.org/0000-0002-5880-3354
ORCID Icon &
Sam Colmand Covance Market Access Services, Labcorp Clinical Development Limited, Sydney, AustraliaORCID Iconhttps://orcid.org/0000-0002-7749-6345
ORCID Icon
Pages 12-19 | Received 13 May 2021, Accepted 27 Jul 2022, Published online: 08 Aug 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.